Hsieh JT - Search Results

1

Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.

Margulis V, Shariat SF, Ashfaq R, Thompson M, Sagalowsky AI, Hsieh JT, Lotan Y. Margulis V, et al. Among authors: hsieh jt. J Urol. 2007 Mar;177(3):1163-8. doi: 10.1016/j.juro.2006.10.033. J Urol. 2007. PMID: 17296438

2

Enhanced transgene expression in androgen independent prostate cancer gene therapy by taxane chemotherapeutic agents.

Li Y, Okegawa T, Lombardi DP, Frenkel EP, Hsieh JT. Li Y, et al. Among authors: hsieh jt. J Urol. 2002 Jan;167(1):339-46. J Urol. 2002. PMID: 11743353

3

Cell adhesion proteins as tumor suppressors.

Okegawa T, Li Y, Pong RC, Hsieh JT. Okegawa T, et al. Among authors: hsieh jt. J Urol. 2002 Apr;167(4):1836-43. J Urol. 2002. PMID: 11912444 Review.

4

Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells.

Pong RC, Lai YJ, Chen H, Okegawa T, Frenkel E, Sagalowsky A, Hsieh JT. Pong RC, et al. Among authors: hsieh jt. Cancer Res. 2003 Dec 15;63(24):8680-6. Cancer Res. 2003. PMID: 14695181

5

Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.

Okegawa T, Nutahara K, Pong RC, Higashihara E, Hsieh JT. Okegawa T, et al. Among authors: hsieh jt. J Urol. 2005 Aug;174(2):747-52. doi: 10.1097/01.ju.0000164723.20555.e6. J Urol. 2005. PMID: 16006969

6

Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.

Zhou J, Hernandez G, Tu SW, Scholes J, Chen H, Tseng CP, Hsieh JT. Zhou J, et al. Among authors: hsieh jt. Cancer Res. 2005 Jul 15;65(14):6089-96. doi: 10.1158/0008-5472.CAN-04-3672. Cancer Res. 2005. PMID: 16024609

7

The application of epigenetic modifiers on the treatment of prostate and bladder cancer.

Zhang Z, Karam J, Frenkel E, Sagalowsky A, Hsieh JT. Zhang Z, et al. Among authors: hsieh jt. Urol Oncol. 2006 Mar-Apr;24(2):152-60. doi: 10.1016/j.urolonc.2005.11.004. Urol Oncol. 2006. PMID: 16520279 Review.

8

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.

Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF. Svatek RS, et al. Among authors: hsieh jt. Cancer. 2006 Apr 15;106(8):1701-7. doi: 10.1002/cncr.21795. Cancer. 2006. PMID: 16541433 Free article.

9

Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model.

Lotan Y, Stanfield J, Cho LC, Sherwood JB, Abdel-Aziz KF, Chang CH, Forster K, Kabbani W, Hsieh JT, Choy H, Timmerman R. Lotan Y, et al. Among authors: hsieh jt. J Urol. 2006 May;175(5):1932-6. doi: 10.1016/S0022-5347(05)00893-1. J Urol. 2006. PMID: 16600801

10

Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model.

Walsh L, Stanfield JL, Cho LC, Chang CH, Forster K, Kabbani W, Cadeddu JA, Hsieh JT, Choy H, Timmerman R, Lotan Y. Walsh L, et al. Among authors: hsieh jt. Eur Urol. 2006 Oct;50(4):795-800; discussion 800. doi: 10.1016/j.eururo.2006.03.021. Epub 2006 Mar 29. Eur Urol. 2006. PMID: 16632182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

413 results

Search Page

Filters